Definitive Contract 75A50120C00019

Award Date 3/13/20
Potential Completion Date 10/15/20
Potential Value $561K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $12.5 million firm fixed-price purchase order to Mesa Biotech, Inc. for the development of the Accula Flu/SARS-CoV-2 Integrated Test. The contract supports the national interest of responding to the coronavirus COVID-19 pandemic through the development of an integrated diagnostic test for influenza and SARS-CoV-2. Performance will take place in San Diego, California over one...
This is a $24,860,014.00 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Mesa Biotech Inc. for the development of an easy-to-use, low-cost molecular-based SARS-CoV-2 test. The contract is part of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development, validation, and commercialization of innovative COVID-19 testing technologies. The contract has a performance period ending on May 4, 2024,...
This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business provider of assay development, testing equipment, and immunoassays. The contract, valued at $23,234,896, is for the acquisition of assays to support COVID-19 vaccine development efforts, in response to a Broad Agency Announcement (BAA) issued by the agency. The contract is a...
This federal contract award is for the "HHS COVID-19 TESTING AND DIAGNOSTIC WORKING" project, which was awarded to the prime contractor, The Mitre Corporation, on September 22, 2021. The contract has a ceiling value of $25,145,175.20 and a period of performance through March 10, 2025. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. The Mitre Corporation is a non-profit organization that operates federally funded research and development centers (FFRDCs) to...
This federal contract award, valued at $6,622,532.37, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business, for "HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY" research and development. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and has a period of performance ending on September 1, 2022. Meso Scale...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, for $102,862.00. The contract is for the delivery of COVID-19 MESO SCALE BRAND V-PLEX SARS-COV-2 PANELS and has a completion date of December 27, 2023. Meso Scale Diagnostics is a for-profit limited liability company that specializes...
This federal contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), provides Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) with a firm fixed-price purchase order worth $45,357.45 to deliver MESO SCALE DIAGNOSTICS MULTI ARRAY AND U-PLEX PLATES. This award has no set-aside designation and is scheduled for completion by August 30, 2024. Meso Scale Diagnostics is a...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines...
This federal contract award to Meso Scale Diagnostics LLC, a small business, was issued by the U.S. Army Research, Development and Engineering Command (RDECOM) for the development of custom biological test kit assays for 14 target agents. The $843,072 firm fixed-price purchase order has a completion date of March 31, 2016. Meso Scale Diagnostics, a provider of assay development services and immunoassay products, has extensive experience supporting federal agencies through prime contracts,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $13,098,630.96 firm fixed price delivery order to Black Mesa Technology Inc. for medical industry bioeconomy security support services. The period of performance is through September 28, 2026. As a for-profit organization, Black Mesa Technology Inc. will provide unspecified products and services to support the Office of the Assistant Secretary for Preparedness and Response's...

Mesa TECH International, Inc., doing business as Mesa TECH Intl., has been awarded a firm fixed-price contract valued at $561,330 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract is to support research and development of a qualitative, visually-read polymerase chain reaction test for COVID-19 under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Work will be performed in San Diego, California from March 13, 2020 through October 15, 2020. Special Instructions 019 sought proposals to develop host-directed therapeutic candidates to aid long-term outcomes from lung injury. Mesa TECH Intl. will pursue safety review of candidates through Phase I and share subsequent data and commercialization plans with the agency.

Generated 12/29/23, 2:29 PM